National Health Investors (NYSE:NHI) Receives “Outperform” Rating from Wedbush
National Health Investors (NYSE:NHI – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Wedbush in a note issued to investors on Monday, MarketBeat Ratings reports. They currently have a $88.00 target price on the real estate investment trust’s stock. Wedbush’s price target would suggest a potential upside of 15.76% from […]
National Health Investors (NYSE:NHI – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Wedbush in a note issued to investors on Monday, MarketBeat Ratings reports. They currently have a $88.00 target price on the real estate investment trust’s stock. Wedbush’s price target would suggest a potential upside of 15.76% from […]
